Routine excretory urography in follow-up of superficial transitional cell carcinoma of bladder.
To determine cost-effective guidelines for the follow-up of patients with superficial transitional cell carcinoma of the bladder (STCCAB), we reviewed clinical histories, pathology reports, and intravenous pyelography results in 84 patients with Stage Ta or T1 disease. In 4 patients (4.8%) subsequent upper tract tumors developed with an average interval from initial presentation to the development of upper tract disease of 5.4 years. Three of these patients were treated successfully. We recommend upper tract surveillance in this group of patients with intravenous pyelography at diagnosis and every twenty-four months thereafter, or selection of those patients who are at high risk for development of upper tract disease (i.e., ureteral-vesical reflux) with voiding cystourethrography one month following each resection of tumors near a ureteral orifice. Refluxing patients should then either undergo surgical repair of their reflux or yearly pyelography.
Smith
H
H
Harry S. Truman Veterans Hospital, Columbia, Missouri.
Weaver
D
D
Barjenbruch
O
O
Weinstein
S
S
Ross
G
G
D002295:Carcinoma, Transitional Cell / Q000000981:diagnostic imaging*; D003362:Cost-Benefit Analysis; D005500:Follow-Up Studies; D006801:Humans; D013997:Time Factors; D001749:Urinary Bladder Neoplasms / Q000000981:diagnostic imaging*; D014567:Urography / Q000379:methods